
Producing cannabinoids through yeast fermentation
Hyasynth Bio is a Montreal-based biotechnology company that produces cannabinoids through yeast fermentation rather than traditional cannabis cultivation. Using a proprietary biosynthesis platform with genetically engineered yeast strains, the company manufactures pure CBD, THC, and other cannabinoids as ingredients for pharmaceutical, nutraceutical, and wellness applications. This fermentation-based approach enables consistent, scalable production without the agricultural inputs required by plant-based extraction.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account